Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials
针对 COVID-19 诱发的急性呼吸窘迫综合征的细胞免疫疗法：CIRCA-19 1 期安全性试验和 2 期随机对照试验的结果
期刊:Stem Cell Reports
影响因子:5.1
doi:10.1016/j.stemcr.2026.102854
English, Shane W; Fergusson, Dean A; Lalu, Manoj Mathew; Courtman, David W; Khan, Saad; Sobh, Mohamad; Watpool, Irene; Champagne, Josee; Hodgins, Samantha; Thébaud, Bernard; Soliman, Karim; Chassé, Michaël; Dos Santos, Claudia C; Möbius, Marius A; Freund, Daniel; Rüdiger, Mario; Stewart, Duncan J
